UAE begins its production of CAR T-cell immune cell therapy

The stem cell revolution is one of the scientific revolutions, which is relied upon to be an important source in the treatment of many chronic diseases and serious injuries, and because the UAE is one of the countries concerned with scientific and medical aspects, the Abu Dhabi Stem Cell Center - the specialized research institute in Abu Dhabi - started the first experiment of its kind In the UAE and the region, to study the efficacy and safety of immune cell therapy known as T-cells using CAR T-cell receptors in the treatment of blood cancers such as myeloma, lymphoma, and certain types of leukemia.

It is noteworthy that immune cell therapy using CAR T-cell receptors is one of the new globally recognized technologies for immunotherapies, which employ the body's defense system by reprogramming immune cells, which is an essential component of the body's anti-tumor response mechanism. It prepares them to carry out the tasks of searching for and eliminating cancer. 

so these programmed cells become a living drug that travels through the body and uses the immune system constantly to attack the disease.